Terra Lara, Beekman Maarten J, Engelhardt Ellen G, Heemskerk-Gerritsen Bernadette A M, van Beurden Marc, Roeters van Lennep Jeanine E, van Doorn Helena C, de Hullu Joanne A, Van Dorst Eleonora B L, Mom Constantijne H, Slangen Brigitte F M, Gaarenstroom Katja N, van der Kolk Lizet E, Collée J Margriet, Wevers Marijke R, Ausems Margreet G E M, Van Engelen Klaartje, van de Beek Irma, Berger Lieke P V, van Asperen Christi J, Gomez Garcia Encarna B, Maas Angela H E M, Hooning Maartje J, Aaronson Neil K, Mourits Marian J E, van Leeuwen Flora E
Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Am J Obstet Gynecol. 2023 Apr;228(4):440.e1-440.e20. doi: 10.1016/j.ajog.2022.11.1289. Epub 2022 Nov 17.
Women with a BRCA1/2 pathogenic variant are advised to undergo premenopausal risk-reducing salpingo-oophorectomy after completion of childbearing, to reduce their risk of ovarian cancer. Several studies reported less sexual pleasure 1 to 3 years after a premenopausal oophorectomy. However, the long-term effects of premenopausal oophorectomy on sexual functioning are unknown.
This study aimed to study long-term sexual functioning in women at increased familial risk of breast or ovarian cancer who underwent a risk-reducing salpingo-oophorectomy either before the age of 46 years (premenopausal group) or after the age of 54 years (postmenopausal group). Subgroup analyses were performed in the premenopausal group, comparing early (before the age of 41 years) and later (at ages 41-45 years) premenopausal risk-reducing salpingo-oophorectomy.
Between 2018 and 2021, 817 women with a high familial risk of breast or ovarian cancer from an ongoing cohort study were invited to participate in our study. Because of a large difference in age in the study between the premenopausal and postmenopausal salpingo-oophorectomy groups, we restricted the comparison of sexual functioning between the groups to 368 women who were 60 to 70 years old at completion of the questionnaire (226 in the premenopausal group and 142 in the postmenopausal group). In 496 women with a premenopausal risk-reducing salpingo-oophorectomy, we compared the sexual functioning between women in the early premenopausal group (n=151) and women in the later premenopausal group (n=345). Differences between groups were analyzed using multiple regression analyses, adjusting for current age, breast cancer history, use of hormone replacement therapy, body mass index, chronic medication use (yes or no), and body image.
Mean times since risk-reducing salpingo-oophorectomy were 20.6 years in the premenopausal group and 10.6 years in the postmenopausal group (P<.001). The mean age at questionnaire completion was 62.7 years in the premenopausal group, compared with 67.0 years in the postmenopausal group (P<.001). Compared with 48.9% of women in the postmenopausal group, 47.4% of women in the premenopausal group were still sexually active (P=.80). Current sexual pleasure scores were the same for women in the premenopausal group and women in the postmenopausal group (mean pleasure score, 8.6; P=.99). However, women in the premenopausal group more often reported substantial discomfort than women in the postmenopausal group (35.6% vs 20.9%; P=.04). After adjusting for confounders, premenopausal risk-reducing salpingo-oophorectomy was associated with substantially more discomfort during sexual intercourse than postmenopausal risk-reducing salpingo-oophorectomy (odds ratio, 3.1; 95% confidence interval, 1.04-9.4). Moreover, after premenopausal risk-reducing salpingo-oophorectomy, more severe complaints of vaginal dryness were observed (odds ratio, 2.6; 95% confidence interval, 1.4-4.7). Women with a risk-reducing salpingo-oophorectomy before the age of 41 years reported similar pleasure and discomfort scores as women with a risk-reducing salpingo-oophorectomy between ages 41 and 45 years.
More than 15 years after premenopausal risk-reducing salpingo-oophorectomy, the proportion of sexually active women was comparable with the proportion of sexually active women with a postmenopausal risk-reducing salpingo-oophorectomy. However, after a premenopausal risk-reducing salpingo-oophorectomy, women experienced more vaginal dryness and more often had substantial sexual discomfort during sexual intercourse. This did not lead to less pleasure with sexual activity.
携带BRCA1/2致病变异的女性在完成生育后,建议进行绝经前降低风险的输卵管卵巢切除术,以降低患卵巢癌的风险。几项研究报告称,绝经前卵巢切除术后1至3年性快感降低。然而,绝经前卵巢切除术对性功能的长期影响尚不清楚。
本研究旨在探讨有乳腺癌或卵巢癌家族高风险的女性,在46岁之前(绝经前组)或54岁之后(绝经后组)接受降低风险的输卵管卵巢切除术的长期性功能情况。在绝经前组中进行亚组分析,比较早期(41岁之前)和晚期(41 - 45岁)绝经前降低风险的输卵管卵巢切除术。
2018年至2021年期间,邀请了来自一项正在进行的队列研究的817名有乳腺癌或卵巢癌家族高风险的女性参与我们的研究。由于绝经前和绝经后输卵管卵巢切除术组在研究中的年龄差异很大,我们将两组之间性功能的比较限制在问卷完成时年龄为60至70岁的368名女性中(绝经前组226名,绝经后组142名)。在496名接受绝经前降低风险的输卵管卵巢切除术的女性中,我们比较了早期绝经前组(n = 151)和晚期绝经前组(n = 345)女性的性功能。使用多元回归分析分析组间差异,并对当前年龄、乳腺癌病史、激素替代疗法的使用、体重指数、慢性药物使用(是或否)和身体形象进行调整。
绝经前组自降低风险的输卵管卵巢切除术后的平均时间为20.6年,绝经后组为10.6年(P <.001)。绝经前组问卷完成时的平均年龄为62.7岁,绝经后组为67.0岁(P <.001)。与绝经后组48.9%的女性相比,绝经前组47.4%的女性仍有性生活(P = 0.80)。绝经前组女性和绝经后组女性当前的性快感得分相同(平均快感得分,8.6;P = 0.99)。然而,绝经前组女性比绝经后组女性更常报告有明显不适(35.6%对20.9%;P = 0.04)。在调整混杂因素后,绝经前降低风险的输卵管卵巢切除术与性交期间明显更多的不适相关,比绝经后降低风险的输卵管卵巢切除术(优势比,3.1;95%置信区间,1.04 - 9.4)。此外,在绝经前降低风险的输卵管卵巢切除术后,观察到更严重的阴道干燥主诉(优势比,2.6;9%置信区间,1.4 - 4.7)。41岁之前接受降低风险的输卵管卵巢切除术的女性报告的快感和不适得分与41至45岁接受降低风险的输卵管卵巢切除术的女性相似。
绝经前降低风险的输卵管卵巢切除术后15年以上,有性生活的女性比例与绝经后降低风险输卵管卵巢切除术的有性生活女性比例相当。然而,绝经前降低风险的输卵管卵巢切除术后,女性经历了更多的阴道干燥,并且在性交期间更常出现明显的性不适。但这并没有导致性活动中的快感减少。